Introduction
Most patients with thyroid microcarcinoma have been reported to have benign clinical courses. On the other hand, those with occult papillary carcinoma have been demonstrated to have invasive courses (Strate et al. 1984) . In studies of 74 thyroid microcarcinoma patients, 5 cases (6.8%) presented with distant metastases with only one case (1.4%) dying of distant metastasis of the occult papillary thyroid carcinoma (Lin et al. 1996 (Lin et al. , 1997b . Early diagnosis and treatment are mandatory for these patients to avoid distant metastases. Ultrasonography and fine needle aspiration cytology (FNAC) were used as diagnostic tools to differentiate a malignant nodule from a benign lesion (Walfish et al. 1977 , Lin et al. 1997a ). Superficial thyroid nodules over 1.0 cm can be detected by an experienced physician using palpation, but deep-seated thyroid nodules are more difficult to locate by physical examination. To investigate the difficulties in the diagnosis of thyroid microcarcinoma and the results of delaying diagnosis for these patients, we retrospectively analyzed the clinical information of 1259 thyroid carcinoma patients in one medical center.
Materials and methods
During a period of 20 years from January 1977 to June 1997, 1259 thyroid cancer patients received treatment and were followed-up at Chang Gung Medical Center in Linkou. From these, 921 cases of papillary thyroid carcinoma were diagnosed and were evaluated for our study. Of these cases, 127 (13.2%) had thyroid 
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Of these 127 thyroid microcarcinoma patients, 94 received pre-operative thyroid ultrasonography with FNAC examinations. Thyroid ultrasonography studies were performed using a real time ultrasonographic machine with a 10 MHz transducer (ALOKA) (Lin et al. 1997a) . For suspected thyroid nodule, FNAC examinations were performed with 22-gauge needles without local anesthesia. If profuse bleeding were encountered, the needle was replaced with a 25-gauge needle. The aspirates were placed in the center of frostedend glass slides, and were air-dried and stained by means of the Romanowsky-based Liu method (Tsou et al. 1997) . All ultrasound and cytological results were interpreted by an attending physician at the Metabolism Division of Linkou Chang Gung Medical Center.
Of the 127 patients, 75 patients received near total thyroidectomy, 41 received subtotal thyroidectomy, and 11 patients received lobectomy. During the operation, frozen sections were performed in 90 patients. After the operation, all the patients received long-term thyroid hormone replacement. Regular cancer check-ups consisting of a 5 mCi 131 I whole body scan, chest X-ray, and serum thyroglobulin (Tg) levels were performed every 6 months. Once the metastatic or recurrent lesions were detected, either surgical treatment or 131 I therapy was suggested. The majority of these patients received regular follow-ups in the Division of Endocrinology and Metabolism, Chang Gung Memorial Hospital. Admission records were reviewed and the following data were recorded using a computer: age, gender, primary tumor size, ultrasonographic findings, aspiration cytology results, thyroid function before the operation, results of Data are presented as means±S.D. and two-tailed, unpaired nonparametric t-tests, chi-square and ANOVA were used to evaluate the statistical significance of the data.
Results
In the study, the 127 patients with thyroid microcarcinoma who received surgical treatment could be divided into four groups. Group I: thyroid microcarcinomas with hyperthyroidism or hyperparathyroidism. Group II: thyroid microcarcinoma with larger benign thyroid nodule or multinodular goiter or thyroid microcarcinoma with nodule goiter coexisting in one patient. The thyroid microcarcinoma in this group was considered an incidental finding. Group III: thyroid microcarcinoma that could be preoperatively detected as thyroid nodule. Group IV: thyroid microcarcinoma that presented with neck lymph node metastases or distant metastases of the thyroid carcinoma. Of the 127 thyroid microcarcinoma patients, 109 were female with a mean age of 40.0±13.1 years and 18 were male with a mean age of 42.3±14.7 years. The age difference between female and male was not statistically different (P=0.49). Forty-five patients were diagnosed as malignancy or suspicious malignancy preoperatively with ultrasonography and FNAC examinations. Clinical presentations and results of preoperative diagnoses of these four groups are shown in Table 1 . Most of the patients in groups I and II had incidental findings of thyroid carcinoma during the operation. Of the 28 patients in group I, 2 patients presented with secondary hyperparathyroidism in end-stage renal disease. Papillary thyroid microcarcinomas were found coexistent with parathyroid hyperplasia. Of the 58 patients in group II, 50 patients received preoperative ultrasonography and FNAC examinations. Only 19 cases (36.5%) were diagnosed preoperatively as malignancy or suspicious malignancy. Figure 1 shows the ultrasonography results of a 47-yearold male patient who presented with a right thyroid nodule measuring 5.1 × 3.4 × 2.3 cm. Ultrasonography revealed an irregular low echo density mass of less than 1 cm in the left thyroid. The patient received near total thyroidectomy after the frozen section demonstrated right thyroid follicular adenoma with left occult papillary thyroid carcinoma measuring about 0.7 cm. The left thyroid microcarcinoma was not detected preoperatively. Figure 2 shows a 30-year-old female patient who presented with a 2.6 cm right thyroid nodule. There was a thyroid microcarcinoma hidden in the solid nodule. The thyroid microcarcinomas could not be aspirated using FNAC examinations only.
Of the 28 patients in group III, 24 received preoperative ultrasonography and FNAC examinations. Eighteen patients (75%) were diagnosed preoperatively as malignancies or suspicious malignancies. Figure 3 shows the ultrasonography results of a 32-year-old female patient who presented with a small neck nodule three months after delivery. FNAC examination was performed on the nodule. Papillary thyroid carcinoma was impressed in the cytology. Thirteen patients in group IV presented with local lymph node metastases or distant metastases of the thyroid cancer. Of the thirteen patients, ten presented with lymph node metastases ( Table 2) . Three patients presented with distant metastases including one with vertebra metastases. One patient presented with skull metastases and another one with lung metastases. Of these thirteen patients in group IV, nine received preoperative ultrasonographic examination. Only four patients were diagnosed as having preoperative malignancy. Figure 4 shows the ultrasonography results of a 22-year-old female patient who presented with neck lymph node. A low echo density mass of about 0.7 cm in size was located in the right thyroid. The mass was proved to be a papillary thyroid carcinoma in the final histopathology. Of the 127 patients, 48 patients received preoperative 99m Tc thyroid scintigraphic examination. The occult tumor could not be precisely localized in these patients.
Tumor size revealed statistically significant differences between the four groups. In groups III and IV, the mean tumor sizes were 0.9±0.2 and 0.8±0.2 cm respectively. Tumors of this size could be detected by an experienced clinician or by ultrasonography. In contrast, the mean tumor size in group I was 0.49±0.24 cm. The small tumors presented in the enlarged goiters and were difficult to detect preoperatively. Of the 127 patients, 7 patients (5.5%) presented with multifocal papillary thyroid carcinomas in the final histopathology. Median follow-up period of these 127 patients was 4.7 years. During this follow-up period, two patients died, including one patient in group IV who died of skull metastasis with brain invasion. Another patient died of stroke which was not related to thyroid carcinoma. Table 2 ). The positions of the sections are shown.
Discussion
In previous studies, most thyroid microcarcinomas followed a rather benign clinical course (Hay et al. 1992 , Van Heerden et al. 1992 . In a recent study we conducted, when we compared the survival or the metastatic rates of the thyroid microcarcinoma patients with nonmicrocarcinoma patients the results did not reveal any differences (Lin et al. 1996) . Most papillary thyroid microcarcinomas had rather benign clinical courses but distant metastases causing mortality were observed (Lin et al. 1997b) . Earlier diagnosis with timely surgical removal of the tumor before distant metastasis may help improve the prognosis in the thyroid microcarcinoma patients. In this study, we analyzed the clinical behavior of thyroid microcarcinomas in patients who were treated in Taiwan. Sixty-five percent (82 of the 127 cases) of the patients were diagnosed during the operation following benign conditions including hyperthyroidism, hyperparathyroidism, or benign thyroid nodules.
As imaging and FNAC examination techniques improve, preoperative diagnosis of thyroid microcarcinoma is not unattainable (Bramley & Harrison 1996) . Recent reports, however, show that even in experienced hands, 76% of the nodules detected by pathological examination were missed by palpation. Fifty-seven percent of the nodules failed to be detected by ultrasonography (Witterick et al. 1993) . In our study, using high resolution ultrasonography with FNAC techniques, 50% of the thyroid microcarcinomas could be detected as malignancy or suspicious malignancy preoperatively. Coexistence of the thyroid microcarcinomas in diffused goiter or larger benign nodule will decrease the diagnostic rate. Most single and superficial thyroid microcarcinomas could be detected preoperatively.
In the current study, 10.2% (13/127 cases) of the thyroid microcarcinomas presented with local lymph node or distant metastases at the time of diagnosis. This percentage leads us to suggest that thyroid microcarcinoma is not an indolent disease. The low diagnostic rate by ultrasonography and FNAC examination was shown in our study, even on patients who presented with local lymph node or distant metastases. In a recent large study series from Noguchi et al. (1997) only 46 of the 867 small carcinomas of the thyroid were diagnosed preoperatively. As in our study, most of the patients underwent operations for benign thyroid disorders. Previous studies had shown that thyroid microcarcinomas may become complicated with distant metastases to the lungs and bone (Boehm et al. 1976 , Hyman 1979 , Osguthorpe & Bratton 1982 , Inci et al. 1994 , Lin et al. 1997a , Moosa & Mazzaferri 1997 . As the results of our study have shown, mortality will occur if important organs are involved (Sillephant et al. 1964 , Stage et al. 1990 . Of the three patients with distant metastases, only one case could be improved to clinical stage 1 after aggressive surgical removal of the bone metastasis. The other two patients remained in clinical stage 4 with lung and bone metastases.
In conclusion, most patients with thyroid microcarcinomas experience a rather benign clinical course. For the thyroid microcarcinomas which are found incidentally in patients with hyperthyroidism or benign thyroid nodules conservative treatment is adequate for all the patients. For patients with thyroid microcarcinomas with distant metastases, aggressive surgical treatment followed by radioactive 131 I treatment is indicated.
